Welcome to LookChem.com Sign In|Join Free

CAS

  • or

98184-57-7

Post Buying Request

98184-57-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

98184-57-7 Usage

Description

2-(3-(Methylsulfinyl)propyl)isoindoline-1,3-dione is a chemical compound that belongs to the isoindoline-1,3-dione derivatives group. It features a sulfide functional group with a sulfur atom bonded to two carbon atoms. 2-(3-(Methylsulfinyl)propyl)isoindoline-1,3-dione has demonstrated potential pharmacological properties, including anti-inflammatory, antioxidant, and anti-cancer activities. It is also known for its ability to inhibit aldose reductase, an enzyme implicated in diabetic complications, and has been studied for its potential in treating cardiovascular diseases and neurodegenerative disorders. However, further research is necessary to elucidate the mechanisms of action and explore its full range of applications.

Uses

Used in Pharmaceutical Industry:
2-(3-(Methylsulfinyl)propyl)isoindoline-1,3-dione is used as a potential therapeutic agent for various conditions due to its anti-inflammatory, antioxidant, and anti-cancer properties. Its ability to inhibit aldose reductase makes it a candidate for the treatment of diabetic complications.
Used in Cardiovascular Disease Treatment:
In the field of cardiology, 2-(3-(Methylsulfinyl)propyl)isoindoline-1,3-dione is used as a potential treatment for cardiovascular diseases, given its pharmacological profile that may help in managing or treating such conditions.
Used in Neurodegenerative Disorder Management:
2-(3-(Methylsulfinyl)propyl)isoindoline-1,3-dione is utilized as a potential therapeutic intervention for neurodegenerative disorders, leveraging its neuroprotective properties to mitigate disease progression.

Check Digit Verification of cas no

The CAS Registry Mumber 98184-57-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,8,1,8 and 4 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 98184-57:
(7*9)+(6*8)+(5*1)+(4*8)+(3*4)+(2*5)+(1*7)=177
177 % 10 = 7
So 98184-57-7 is a valid CAS Registry Number.

98184-57-7Downstream Products

98184-57-7Relevant articles and documents

Nucleoside analogs. 14. The synthesis and antitumor activity in mice of molecular combinations of 5-fluorouracil and N-(2-chloroethyl)-N-nitrosourea moieties separated by a three-carbon chain

McElhinney, R. Stanley,McCormick, Joan E.,Bibby, Mike C.,Double, John A.,Radacic, Marco,Dumont, Patrick

, p. 1408 - 1412 (2007/10/03)

5-Fluorouracil (5-FU) seco-nucleosides having as the "sugar" moiety a two-carbon (C2) side chain carrying a N-(2-chloroethyl)-N-nitrosourea group were designed as molecular combinations of antimetabolite and alkylating agent, but hydrolytic release of free 5-FU was not fast enough for significant contribution to the high activity they showed against colon and breast tumors in mice. In the present study of the synthesis of the more reactive C3 seco-nucleosides, it emerged that, of various groups attached to the aldehydic center in the precursor phthalimides, only the alkoxy/uracil-1-yl type was conveniently obtained by the standard method. The methylthio/uracil-1-yl analog required relatively large amounts of reagent methanethiol, and exploration of alternatives involving α-chlorination of alkyl methyl sulfide or Pummerer rearrangement of its S-oxide, or successive hydrolysis and methylation of isothiouronium bromide, gave disappointing yields. For successful preparation of the alkoxy/ uracil-3-yl compounds, the route used for C2 homologs required considerable experimental modification. In addition to these O,N- and S,N-acetals, some N,N-acetals bearing two 5-FU residues were prepared. The new drugs have been tested against a panel of experimental tumors in mice. Although it is evident from a parallel study that even these C8 seco-nucleosides release free 5-FU too slowly in vivo, several of them have shown impressive anticancer activity. Reviewing their performance in comparison with earlier molecular combinations, a short list of seven [B.4152 (6), B.4015 (5), B.4030 (10), B.3999 (4), B.3995 (2), B.4083 (3), and B.3996 (the N3-substituted analog of 1)] should be investigated further. This is particularly appropriate in light of the present understanding of the mode of action of chloroethylating agents. Following a prolonged period of clinical impatience with nitrosoureas because of limited selectivity of action, a new era is confidently anticipated as these powerful drugs are increasingly studied in combination with O6-benzylguanine and other more efficient inhibitors of repair enzymes like O6-alkylguanine-DNA-alkyltransferase now being developed.

Photochemistry of N-phthaloyl derivatives of methionine

Griesbeck, Axel G.,Mauder, Harald,Mueller, Ingrid,Peters, Eva-Maria,Peters, Karl,Von Schnering, Hans Georg

, p. 453 - 456 (2007/10/02)

Photocarboxylation of N-phthaloyl derivatives of methionine sulfoxide 1b and methionine sulfone 1c was observed in acetone as the major reaction. For 1a a fast electron transfer initiated cyclization which leads to the bicyclization product 3 (X-ray structure)was observed in the sensitized photolysis. Direct photolysis of 1a leads preferentially to the tricylic product 4 and the decarboxylation product 5. The methionine methyl ester 6a-c showed electon transfer initiated cyclization (for 6a) and disproportionation (for 6b), whereas 6c proved to be photostable.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 98184-57-7